Search Results
Jul 28, 2026, 06:02 ET American Lung Association Highlights Therapeutic Options Available to Prevent and Treat COVID-19
Lung.org/hcp-covid.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by
More news about: American Lung Association
Jul 23, 2026, 10:01 ET PulsePoint and CMI Media Group Launch the First Agency Activation of HCP2DTC Influence™
to be the first agency to bring HCP2DTC Influence™ to market and unlock this solution for our clients."This deployment marks the first agency commercial activation of HCP2DTC Influence™ and validates the solution's ability to drive measurable impact across both HCP and DTC audiences within a unified
More news about: PulsePoint
Jul 21, 2026, 10:15 ET Prezent Vivo 1.0 accelerates AI-native med comms with AI-generated posters and fixed-price scientific delivery
hours.Scientific Posters: Transforms accepted abstracts into congress-ready, print-ready posters within 72 hours, with optional digital ePosters, HCP presentations, and plain-language summaries.Overnight Editorial ServicesPrezent Vivo 1.0 also expanded managed services with
More news about: Prezent
Jul 14, 2026, 12:15 ET Doceree Launches the Analytics Workbench: Closed Loop Measurement Without the Closed System
today launched the Analytics Workbench, the open measurement layer of Daily Command. Earlier this month, Doceree closed the measurement loop across nine HCP channels — Investment, Reach, Performance, and Outcome, read through one clinical signal. The Workbench opens that foundation to what no platform can
More news about: Doceree
Jul 14, 2026, 12:11 ET Doceree Unveils Semmelweis: The First AI Model Purpose-Built for Pharma Commercialization
of guessing from demographics.A compliance-bounded action space. The model never touches patient data. It works only on de-identified, HCP-level context and can recommend only actions that already sit within medical, legal, and regulatory guidelines — advisory, human-approved, auditable,
More news about: Doceree
Jul 14, 2026, 12:02 ET Doceree Launches Generative AI Connectors, Bringing Clinical Intelligence to ChatGPT and Claude
because it does not live in the channel — it lives in the model beneath it. Semmelweis never touches patient data. It operates solely on de-identified, HCP-level context, and every action it recommends on a generative platform— like every action anywhere else in the system — sits within medical, legal, and
More news about: Doceree
Jul 14, 2026, 11:41 ET More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
functional assessments, and healthcare professional (HCP) implementation learnings in diverse US clinical settings for patients with early AD. The study integrated deidentified chart and electronic medical record (EMR) data from 13 US sites, HCP surveys and HCP interviews. This interim analysis included 432
More news about: BioArctic
Jul 14, 2026, 11:40 ET Doceree Launches Daily Command: The First Commercial Operating System for Pharma, Powered by Semmelweis
physician sits within a treatment decision rather than inferring intent from demographics. It never accesses patient data, operates solely on de-identified, HCP-level context, and recommends only actions that already fall within medical, legal, and regulatory guidelines — every recommendation advisory, human-approved,
More news about: Doceree
Jul 14, 2026, 11:39 ET More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
functional assessments, and healthcare professional (HCP) implementation learnings in diverse US clinical settings for patients with early AD. The study integrated deidentified chart and electronic medical record (EMR) data from 13 US sites, HCP surveys and HCP interviews. This interim analysis included 432
More news about: BioArctic
Jul 14, 2026, 11:15 ET LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
assessments, and healthcare professional (HCP) implementation learnings in diverse U.S. clinical settings for patients with early Alzheimer's disease (AD). The study integrated deidentified chart and electronic medical record (EMR) data from 13 U.S. sites, HCP surveys and HCP interviews. This interim analysis
More news about: Eisai Inc.
Jul 08, 2026, 08:51 ET Doceree Closes the Measurement Loop Across Every HCP Channel
A unified Closed Loop Measurement framework now connects Investment, Reach, Performance, and Outcome across nine HCP channels: Point of Care, Programmatic, Account-Based Marketing, Copay, CTV, DOOH, Social, Email, and Text. The framework is powered by Clinical Intent Signals, attention-based
More news about: Doceree
Jul 07, 2026, 08:28 ET Instar Brands and Heretic Capital Partners Outline Framework for a Potential Aladdin's Castle Arcade Revival
Aladdin's Castle, and under a joint venture between Instar Brands and HCP, the parties are evaluating the potential relaunch of physical Aladdin's Castle arcade locations. Any such relaunch would be funded through an equity investment by HCP, consistent with the firm's role as an investment firm, and would
More news about: Instar Brands
Jun 26, 2026, 16:50 ET SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
prefilled cartridge with on-body injector.This is the most important information to know about SKYRIZI. For more information, talk to your HCP.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
More news about: AbbVie
Jun 26, 2026, 07:16 ET Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Because severe renal impairment increases pirtobrutinib exposure, reduce Jaypirca dose in these patients according to approved labeling.PT HCP ISI MCL_CLL Q42025Please see
More news about: Eli Lilly and Company
Jun 25, 2026, 09:00 ET Health Union Launches 2027 Innovation Suite, Pairing Community Leadership with AI to Accelerate Patient and HCP Connections
Union. "Our 2027 tools use AI to make those connections more personalized, while always prioritizing the human voice at the center."Coordinated HCP and DTC Activation - Powered by CommunityEffective health marketing requires closing the loop between the patient's lived experience and the
More news about: Health Union
Jun 25, 2026, 08:45 ET Assembled Intelligence Elevates Its AI Practice, Names Chuck Hemann as Chief Business and AI Officer
day-to-day workflows."What we've built is different: it starts with domain expertise — the science, the payer logic, the patient, caregiver, and HCP experience, the brand strategy, the creative instinct — and uses AI to make that expertise faster to apply and harder to replicate. That's what our clients
More news about: Assembled Intelligence
Jun 23, 2026, 13:00 ET PulsePoint Expands Omnichannel Intelligence with Ad Server Creative ID Reporting, Giving Marketers NPI-Level Visibility into Rotating Creatives
served to each individual HCP, even when multiple creatives are rotating within the same ad server placement. Combined with PulsePoint's existing channel-level behavioral data, marketers can now optimize by both channel and creative simultaneously to understand not just where an HCP engages, but what message
More news about: PulsePoint
Jun 23, 2026, 11:00 ET Doceree Unveils Trigger DOOH, Bringing True Addressability to Healthcare Out-of-Home Advertising for the First Time
Triggers™ technology, it allows marketers to plan, activate, measure, and optimize DOOH alongside endemic digital, EHR-integrated point-of-care, and HCP engagement channels.Life science brands and agencies interested in early access can visit
More news about: Doceree
Jun 23, 2026, 10:00 ET UPSHER-SMITH EXPANDS KYMBEE™ (DEFLAZACORT) FAMILY OF PRODUCTS WITH LAUNCH OF ORAL SUSPENSION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
https://mykymbee.com/hcp. If you or your doctor have questions about KYMBEE™, reach out to Upsher-Smith at 1-888-650-3789.IMPORTANT SAFETY INFORMATION
More news about: Upsher-Smith Laboratories, LLC
Jun 22, 2026, 09:01 ET PrescriberPoint Expands Leadership Team, Appointing Steven Strongwater, M.D., as Chief Medical Officer
PrescriberPoint reached more than 5 million healthcare professionals, including prescribers and staff, establishing it as one of the largest active HCP networks in digital health. That scale gives life sciences companies a direct line into the prescribing moment — reducing access barriers and driving
More news about: PrescriberPoint
Jun 22, 2026, 09:00 ET SmartTRAK Launches SmartTARGET, Bringing Physician-Level Procedure Data and Orthopedic, Wound and Neuro Market Intelligence Together in One Platform
powerful insights and physician level targeting together in one place, activating instantly within your existing workflow. Users can search and filter by HCP name, NPI number, specialty, geography, CPT and HCPCS Level II procedure codes. Open Payments data further enriches targeting by surfacing physician-manufacturer
More news about: SmartTRAK
Jun 16, 2026, 09:41 ET Doceree Recognized in the Gartner® Hype Cycle™ for Life Science Enterprise Technologies, 2026
governed, in-workflow conversational engagement has become to the future of HCP interaction The company has spent over five years building the infrastructure that makes that engagement possible at scale — from its proprietary HCP identity graph and point-of-care integrations to RepTwin, its AI agent for
More news about: Doceree
Jun 16, 2026, 09:01 ET PulsePoint's HCP2DTC Influence™ Brings HCP Signals and Intelligence to DTC Campaigns for Greater Precision and Impact
prescription by as much as 50%.HCP2DTC Influence™ runs on Pulsepoint's first-party HCP data foundation, a meaningful distinction, with PulsePoint being the only platform operating at this level of HCP precision at scale."It's about understanding the HCP signals like the scripts they are writing
More news about: PulsePoint
Jun 15, 2026, 08:00 ET DeepIntent Launches Helix AI, Bringing Agentic AI and Cross-Platform Activation to Healthcare Marketers
launch planning.Integrate HCP & DTC Insights: Explore HCP and consumer populations together in a single conversation, connecting insights across the healthcare ecosystem.Build & Activate Audiences: Create HealthFirst™ HCP and DTC audiences using natural language
More news about: DeepIntent
Jun 14, 2026, 03:15 ET Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Because severe renal impairment increases pirtobrutinib exposure, reduce Jaypirca dose in these patients according to approved labeling.PT HCP ISI MCL_CLL Q42025Please see
More news about: Eli Lilly and Company